A phase I trial investigating safety, tolerability and pharmacokinetics of INV-347
Latest Information Update: 06 May 2024
At a glance
- Drugs INV 347 (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 06 May 2024 New trial record